AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 2- Open
- $2.38
- 52-wk high
- $5.55
- High
- $2.41
- 52-wk low
- $1.03
- Low
- $2.12
- Prev close
- $2.90
- Mkt cap
- $194.3M
- Volume
- 8.15M
- Beta
- 1.34
- P/S
- 17.6x
- P/B
- 24.4x
- Profit margin
- +0.0%
- Op margin
- -813.0%
- ROE
- -179.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PYXS filings
Are insiders buying or selling Pyxis Oncology Inc (PYXS) stock?
Neither. Pyxis Oncology Inc (PYXS) insiders filed no open-market purchases or sales in the 90 days to Oct 2, 2026, according to SEC Form 4 filings.
Which members of Congress have traded PYXS recently?
None. No member of Congress disclosed a PYXS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PYXS smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders are trading both ways.
What insiders are doing
Sells (1)
- DJ
Dupont Jakob
$107K
sold
How top traders are positioned
No tracked top-trader positions in PYXS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 14.3% below what analysts expected.
Last report
Aug 13, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.35 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | -$0.40 / -$0.35Yahoo Finance | -14.29% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 14, 2026 | -$0.37 / -$0.35Yahoo Finance | -4.72% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 23, 2026 | -$0.29 / -$0.34Yahoo Finance | +14.43% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 3, 2025 | -$0.35 / -$0.34Yahoo Finance | -3.38% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 14, 2025 | -$0.30 / -$0.35Alpha Vantage | +14.29% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 15, 2025 | -$0.35 / -$0.29Alpha Vantage | -20.69% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 18, 2025 | -$1.32 / -$0.32Alpha Vantage | -$1.00 miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.35 / -$0.31Alpha Vantage | -12.90% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 2, 2026, in 31 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $194M
Valuation
- P/S17.61
- P/B24.42
Quality
- Operating margin-813.0%
- ROE-179.1%
- ROA-62.9%
Growth
- Beta1.34
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace